Window-of-opportunity trials to evaluate clinical activity of new molecular entities in oncology
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Window-of-opportunity trials to evaluate clinical activity of new molecular entities in oncology
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 22, Issue 8, Pages 1717-1725
Publisher
Oxford University Press (OUP)
Online
2011-01-15
DOI
10.1093/annonc/mdq622
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- International multicenter randomized phase III study of first-line erlotinib (E) followed by second-line cisplatin plus gemcitabine (CG) versus first-line CG followed by second-line E in advanced non-small cell lung cancer (aNSCLC): The TORCH trial.
- (2017) C. Gridelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
- (2010) J. E. Dancey et al. CLINICAL CANCER RESEARCH
- Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia
- (2010) Andrea Meinhardt et al. JOURNAL OF CLINICAL ONCOLOGY
- Bar the Windows but Open the Door to Randomization
- (2010) Mark J. Ratain JOURNAL OF CLINICAL ONCOLOGY
- Clinical and economic value of screening for Kras mutations as predictors of response to epidermal growth factor receptor inhibitors
- (2009) E. E. Mancl et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Long-term follow-up of chemonaive patients with asymptomatic metastatic colorectal cancer treated with enzastaurin in a window of opportunity phase II study
- (2009) B. Glimelius et al. ANNALS OF ONCOLOGY
- A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer
- (2009) B. Glimelius et al. ANNALS OF ONCOLOGY
- Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study
- (2009) J. Tabernero et al. ANNALS OF ONCOLOGY
- Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer
- (2009) P. Bystrom et al. ANNALS OF ONCOLOGY
- Targeted therapies in the treatment of advanced/metastatic NSCLC
- (2009) A.G. Pallis et al. EUROPEAN JOURNAL OF CANCER
- Issues in Using Progression-Free Survival When Evaluating Oncology Products
- (2009) Thomas R. Fleming et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
- (2009) Christopher G. Azzoli et al. JOURNAL OF CLINICAL ONCOLOGY
- Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment
- (2009) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent advances of novel targeted therapy in non-small cell lung cancer
- (2009) Jed A Katzel et al. Journal of Hematology & Oncology
- Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology
- (2009) Cesare Gridelli et al. LUNG CANCER
- Optimising the design of phase II oncology trials: The importance of randomisation
- (2008) Mark J. Ratain et al. EUROPEAN JOURNAL OF CANCER
- Short Preoperative Treatment With Erlotinib Inhibits Tumor Cell Proliferation in Hormone Receptor–Positive Breast Cancers
- (2008) Marta Guix et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations on the Use of 18F-FDG PET in Oncology
- (2008) J. W. Fletcher et al. JOURNAL OF NUCLEAR MEDICINE
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
- (2008) Bernard Nordlinger et al. LANCET
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: A report from the Children's Oncology Group
- (2008) Peter E. Zage et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More